Your session is about to expire
← Back to Search
CAMAROS Trial Summary
This trial is testing whether a CCR5 antagonist coupled with exercise can improve upper and lower extremity recovery after a stroke.
CAMAROS Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
CAMAROS Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2008 Phase 4 trial • 18 Patients • NCT00666705
CAMAROS Trial Design
Find a Location
Who is running the clinical trial?
- You can move your shoulder and fingers in certain ways.You have difficulty moving your hips.You are 18 years old or older.You have weakness on one side of your body that requires you to stay in a rehabilitation facility.You are able to move your shoulder and fingers, or your hip, in certain ways.You have had a specific type of stroke in the front part of your brain.You have access to help for daily rehabilitation training and transportation if needed.You had a stroke at least 5 days ago, but no more than 6 weeks ago when the study medication (maraviroc or placebo) is started.You have weakness on one side of your body that requires staying in a rehabilitation facility.This criterion means that at least one of the following conditions or requirements must be met.You had a stroke in the front part of your brain caused by a lack of blood flow.You had difficulty with daily activities before the stroke.You do not have enough resources or are too sick to live outside of a care facility.You have a history of memory and thinking problems.You have a history of liver disease or high liver enzyme levels.You have had kidney problems or your kidneys are not working well.You have a serious illness that may make it hard for you to exercise and practice new skills, or may make it unlikely for you to live for another year.You have had a seizure caused by a stroke.You are currently using St. John's Wort.You have had a certain type of stroke in the front part of your brain.You are 18 years old or older.You have weakness on one side of your body that requires inpatient rehabilitation.You can move your shoulder or hip in specific ways.For the upper extremity group, you need to have a certain level of strength in your shoulder and fingers, and a specific score on an assessment test.People who need help from two others to move or walk very slowly with limited hip movement.You are currently taking Carbamazepine, Phenobarbital, or Phenytoin for seizures.You have HIV.You are currently taking certain antifungal or antibacterial medications like ketoconazole, itraconazole, voriconazole, rifampin, clarithromycin, rifabutin, or protease inhibitors.You have a serious disabling illness before the stroke, like Parkinson's disease or severe brain injury.You have epilepsy.
- Group 1: Maraviroc (Celsentri)
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the Maraviroc's standing with the FDA?
"Maraviroc's safety is only supported by Phase 2 trial data, which means that while there is some evidence of its safety, there is none for its efficacy. Thus, we've given it a score of 2."
What other research studies have included Maraviroc as a treatment?
"Maraviroc was first studied in 2009 at IRCCS Ospedale Pediatrico Bambino Gesu. To date, 18399 trials have been completed while 5 studies are still recruiting patients. These clinical trials tend to be based in Vancouver, Canada."
How many test subjects are required for this experiment?
"This particular study has completed recruitment for patients. The trial was posted on May 1st, 2022 and updated two days later. However, there are presently 1085 clinical trials actively searching for patients with stroke and 5 trials for Maraviroc that still require participants."
Are participants still being signed up for this experiment?
"This study is not currently looking for more patients. It was originally posted on May 1st, 2022 and last updated on the second of the same month. There are 1085 other trials related to stroke that are still recruiting patients, as well as 5 studies centred around Maraviroc."
Is this a groundbreaking new study?
"At this moment in time, there are 5 ongoing clinical trials involving Maraviroc taking place in 27 cities and 12 countries. The first study was completed in 2009 by ViiV Healthcare. A total of 103 patients were used in the Phase 2 drug approval stage trial. In the 11 years since 2009, a grand total of 18399 additional trials have been conducted."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Sunnybrook Health Sciences Centre: < 48 hours
Average response time
- < 2 Days
Share this study with friends